Recruiting
Phase 3

Tildrakizumab

Sponsor:

Sun Pharmaceutical Industries Limited

Code:

NCT04314544

Conditions

Active Psoriatic Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TILD

matching placebo injections

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information